Catherine M. Guly

Bristol, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First-Line Therapy.

Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First-Line Therapy.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 20, 2025

Uveitis in Adults: A Review.

Uveitis in Adults: A Review.

Journal: JAMA

Published: May 28, 2025

Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis.

Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis.

Journal: Arthritis care & research

Published: January 23, 2025

Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis.

Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis.

Journal: Arthritis care & research

Published: January 23, 2025

Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis.

Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis.

Journal: Pediatric rheumatology online journal

Published: November 06, 2024

The management of adult and paediatric uveitis for rheumatologists.

The management of adult and paediatric uveitis for rheumatologists.

Journal: Nature reviews. Rheumatology

Published: October 07, 2024

Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.

Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.

Journal: Lancet (London, England)

Published: August 30, 2024

Management of JIA associated uveitis.

Management of JIA associated uveitis.

Journal: Best practice & research. Clinical rheumatology

Published: March 07, 2024

Long-Term Visual Outcome of Patients with Blau Syndrome.

Long-Term Visual Outcome of Patients with Blau Syndrome.

Journal: Ocular immunology and inflammation

Published: January 05, 2024

Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis.

Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis.

Journal: Ocular immunology and inflammation

Published: February 21, 2023

Childhood Chronic Idiopathic Uveitis in a Multicentre International Cohort.

Childhood Chronic Idiopathic Uveitis in a Multicentre International Cohort.

Journal: Ocular immunology and inflammation

Published: February 21, 2023

Similarities in the histological mouse model of early herpes simplex retinopathy with punctate inner choroidopathy and Ebola virus disease retinopathy.

Similarities in the histological mouse model of early herpes simplex retinopathy with punctate inner choroidopathy and Ebola virus disease retinopathy.

Journal: European journal of ophthalmology

Published: December 12, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026